V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240016295 | 240007111 | null | 80.4 | Curative (C) | 2015-10-20 | 2015-10-26 | Rituximab | N | null | 240026622 | RITUXIMAB |
| 240016296 | 240014116 | null | 72.6 | Palliative (P) | 2018-03-23 | 2018-03-23 | Rituximab | N | N | 240028055 | RITUXIMAB |
| 240016297 | 240011960 | 1.52 | 71 | Disease modification (D) | 2015-11-10 | 2015-11-17 | CHOP R | 02 | N | 240028481 | CHOP R |
| 240016298 | 240012010 | 1.77 | 72 | Curative (C) | 2017-02-08 | 2017-06-12 | CHOP R - 21 days | N | N | 240029181 | CHOP R |
| 240016299 | 240012023 | 1.68 | 52.6 | Curative (C) | 2019-04-12 | 2019-06-07 | Cisplatin 7 day | N | N | 240029327 | CISPLATIN |
| 240016301 | 240007532 | null | null | Curative (C) | 2020-02-15 | 2020-02-19 | CHOP R - 21 days | N | N | 240029614 | CHOP R |
| 240016302 | 240007618 | 1.8 | 50.7 | Curative (C) | 2018-04-21 | 2018-05-20 | Cisplatin + Radiotherapy | N | null | 240030073 | CISPLATIN + RT |
| 240016303 | 240007668 | null | 53.35 | null | null | 2014-09-23 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240030419 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240016304 | 240014222 | 1.06 | null | Curative (C) | 2019-10-02 | 2019-11-04 | Trial Unspecified | N | N | 240030734 | TRIAL |
| 240016305 | 240007724 | 1.49 | 97 | Palliative (P) | 2017-10-15 | 2017-10-23 | Azacitidine | N | N | 240030765 | AZACITIDINE |
| 240016306 | 240007736 | 1.67 | 55.1 | Curative (C) | 2017-02-13 | 2017-02-15 | Azacitidine | 01 | N | 240030813 | AZACITIDINE |
| 240016307 | 240015293 | 1.68 | 63.6 | null | 2019-08-20 | 2019-08-20 | CHOP - 21 days | 02 | N | 240030997 | CHOP |
| 240016308 | 240007806 | 1.8 | 69 | Not known (9) | 2018-07-23 | 2018-08-12 | INTERLACE TRIAL | N | null | 240031247 | INTERLACE TRIAL |
| 240016309 | 240012195 | 1.64 | 62.8 | Curative (C) | 2017-12-16 | 2019-12-17 | Carboplatin AUC 6 - 10 | 2 | N | 240031288 | CARBOPLATIN |
| 240016310 | 240007871 | null | 61.6 | Palliative (P) | null | 2019-06-10 | Bevacizumab | 99 | null | 240031664 | BEVACIZUMAB |
| 240016311 | 240007924 | 0 | null | null | 2017-02-19 | 2017-06-25 | Bevacizumab+Carbo+Pacliaxel | Y | null | 240031919 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240016312 | 240012258 | null | 61.1 | Adjuvant (A) | 2018-06-02 | 2018-06-02 | INTERLACE TRIAL | 02 | N | 240032061 | INTERLACE TRIAL |
| 240016313 | 240016118 | 1.71 | 73.8 | Curative (C) | 2014-03-10 | 2014-04-08 | CHOP | N | N | 240032483 | CHOP |
| 240016314 | 240008040 | 1.7 | 94.6 | Curative (C) | 2017-09-23 | 2017-09-25 | PACLITAXEL | N | N | 240032533 | PACLITAXEL |
| 240016315 | 240008054 | 0 | 50.8 | null | 2019-05-02 | 2019-05-09 | CHOP - 21 days | N | N | 240032600 | CHOP |
| 240016316 | 240008186 | 1.66 | 71.6 | Curative (C) | 2017-06-07 | 2017-06-11 | Trastuzumab Subcutaneous | N | null | 240033543 | DA |
| 240016317 | 240008204 | 1.83 | null | Palliative (P) | 2018-08-31 | 2018-08-31 | Brentuximab | 02 | N | 240033648 | BRENTUXIMAB |
| 240016318 | 240008235 | 1.7 | 103 | Curative (C) | 2018-11-26 | 2018-11-28 | Cyclophosphamide High Dose | 02 | N | 240033833 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 240016319 | 240008282 | 1.82 | 62.4 | Curative (C) | 2018-07-16 | 2019-02-18 | LENALIDOMIDE | N | N | 240034124 | DA |
| 240016320 | 240008290 | null | 98 | Palliative (P) | 2015-08-29 | 2015-09-03 | TRASTUZUMAB | N | null | 240034148 | METHOTREXATE |
| 240016321 | 240008367 | 1.8 | null | Disease modification (D) | 2019-04-06 | 2019-06-10 | FLAG + Idarubicin | N | N | 240034537 | TRASTUZUMAB |
| 240016322 | 240008385 | 1.63 | 63.7 | Curative (C) | 2014-08-21 | 2014-08-21 | Brentuximab | 2 | N | 240034689 | BRENTUXIMAB |
| 240016323 | 240008450 | 1.6 | null | Curative (C) | 2016-03-01 | 2016-04-12 | Methotrexate High Dose (3g/m2) | 1 | Y | 240035134 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240016324 | 240012526 | 1.75 | 112 | Palliative (P) | 2014-06-08 | 2014-06-15 | LENALIDOMIDE | null | null | 240035318 | METHOTREXATE HIGH DOSE |
| 240016325 | 240012544 | 1.56 | 75.5 | Palliative (P) | 2018-10-16 | 2019-01-16 | Chlorambucil | 2 | N | 240035459 | CHLORAMBUCIL |
| 240016326 | 240008499 | 1.69 | null | Palliative (P) | null | 2015-02-15 | Cytarabine Low Dose | 2 | N | 240035460 | GEMCITABINE |
| 240016327 | 240008521 | 1.63 | 55.6 | Palliative (P) | 2015-06-02 | 2015-10-27 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 240035582 | CYTARABINE |
| 240016328 | 240012581 | null | 59.5 | Palliative (P) | 2017-11-08 | 2018-01-13 | LENALIDOMIDE | 01 | N | 240002486 | GEMCITABINE |
| 240016329 | 240008585 | 1.6 | 60.3 | Palliative (P) | 2017-09-28 | 2017-09-30 | Chlorambucil | N | N | 240003250 | CHLORAMBUCIL |
| 240016330 | 240008682 | null | 60.7 | Palliative (P) | 2017-04-09 | 2017-06-01 | DA 3+8 | N | null | 240009661 | BEAM |
| 240016331 | 240008714 | 1.65 | 64.95 | Curative (C) | 2018-05-13 | 2019-01-15 | CARMUSTINE + CYTARABINE + ETOPOSIDE | Y | N | 240011523 | GEMCITABINE + OXALIPLATIN |
| 240016332 | 240008780 | 1.65 | 25 | Curative (C) | 2018-11-01 | 2018-11-04 | DA-EPOCH-R | 2 | N | 240016111 | NHL 2003 |
| 240016333 | 240016278 | 1.59 | 82.8 | Palliative (P) | 2017-02-02 | 2017-02-07 | Liposomal Doxorubicin (Caelyx) | 02 | N | 240018081 | AML18 TRIAL |
| 240016334 | 240016338 | 1.52 | 54 | Curative (C) | 2019-01-17 | 2019-02-03 | Carboplatin + Topotecan | 02 | N | 240019353 | CAPECITABINE |
| 240016335 | 240012718 | 1.6 | 64.6 | Disease modification (D) | 2018-11-29 | 2018-12-03 | Vinorelbine (oral) | 02 | N | 240020386 | UKALL2014 |
| 240016336 | 240012722 | 1.77 | 78 | Curative (C) | 2020-05-28 | 2020-05-31 | BLEOMYCIN + CHLORAMBUCIL + LOMUSTINE + METHOTREXATE + RITUXIMAB + VINBLASTINE | 2 | N | 240020689 | CYTARABINE + RITUXIMAB |
| 240016337 | 240008850 | 1.61 | 54 | Palliative (P) | 2016-04-12 | 2016-04-15 | REMODLB TRIAL | 2 | N | 240020856 | BENDAMUSTINE + OBINUTUZUMAB |
| 240016338 | 240012769 | 1.68 | 49 | Disease modification (D) | 2018-06-13 | 2018-06-26 | Irinotecan + Modified De Gramont | N | N | 240023933 | ETOPOSIDE |
| 240016339 | 240012827 | null | 94.9 | Palliative (P) | 2018-03-28 | 2018-08-22 | Doxorubicin 75mg/m2 | 02 | N | 240015030 | DOCETAXEL + GEMCITABINE |
| 240016340 | 240005775 | 1.66 | null | Palliative (P) | 2018-02-10 | 2019-03-28 | Rituximab | N | N | 240004078 | RITUXIMAB |
| 240016341 | 240006210 | 1.75 | 90.8 | Disease modification (D) | 2020-12-23 | 2020-12-30 | Rituximab | 02 | N | 240009601 | RITUXIMAB |
| 240016342 | 240006358 | 1.61 | null | Curative (C) | 2016-06-02 | 2016-06-05 | Rituximab | 2 | N | 240010555 | RITUXIMAB |
| 240016343 | 240006515 | null | 70 | Curative (C) | 2018-07-19 | 2018-07-20 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 240011479 | RITUXIMAB |
| 240016344 | 240006594 | 1.55 | 61 | Curative (C) | 2014-12-07 | 2014-12-11 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | null | 240011964 | RITUXIMAB |
| 240016346 | 240007712 | 1.58 | 63.6 | Curative (C) | 2019-10-12 | 2019-11-25 | BUSULFAN + THIOTEPA | N | N | 240030734 | NOT MATCHED |